The state-of-the-art Targeted Therapy services offered by Jaslok Hospital & Research Center, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Mumbai, India. Founded in 1973, the NABH, JCI accredited hospital has 350 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.